Venom Producing
Order and Quotation Process
You may submit your request by creating an order from our product portfolio. Upon order confirmation, your contact details will be requested in order to provide pricing and supply information. Following internal review, our official quotation and process details will be sent to the provided contact information within a maximum of two (2) business days via email.
Please Click The Related Category For Seeing Our Products
Scorpion Breeding, Milking, and Venom Supply Policy
​
At G Biological Products, we operate under a strict scientific, ethical, and sustainability-driven framework for the breeding of scorpions, the extraction of venom, and the downstream handling of venom-derived materials. Scorpion venom represents one of the most complex naturally occurring bioactive matrices, containing a diverse spectrum of peptides, enzymes, and low-molecular-weight compounds with significant biomedical, pharmaceutical, and biotechnological relevance. Our policies are designed to ensure the highest standards of animal welfare, product integrity, traceability, and scientific reproducibility.
All scorpions used in our operations are captive-bred within controlled laboratory environments. Breeding programs are established and maintained to eliminate dependence on wild populations, thereby supporting biodiversity conservation and ecological sustainability. Environmental parameters including temperature, humidity, photoperiod, nutrition, and habitat structure are continuously monitored and optimized according to species-specific biological requirements. Each breeding colony is documented, and population health indicators are routinely assessed by trained personnel.
Venom extraction (milking) is conducted exclusively using non-lethal, minimally invasive electrostimulation techniques that are widely accepted within scientific and veterinary communities. This method allows for the safe release of venom without causing permanent harm, stress-related mortality, or long-term physiological impairment to the scorpion. Extraction intervals are carefully scheduled to respect natural venom regeneration cycles, ensuring both animal welfare and consistent venom quality.
All milking procedures are performed by specialized technicians under standardized operating protocols (SOPs). Each extraction session is recorded, and individual scorpions are tracked to maintain full batch-level traceability. Following extraction, scorpions are returned to their controlled habitats and monitored for post-procedure recovery.
The collected venom undergoes controlled handling, stabilization, and purification processes within secure laboratory environments. Depending on intended use, venom may be supplied in crude, clarified, lyophilized, or fractionated forms. Quality control measures include sterility checks, biochemical profiling, protein and peptide characterization, and storage condition validation. These processes ensure consistency, safety, and suitability for research, pharmaceutical development, diagnostic applications, and industrial biotechnology.
G Biological Products adheres to international ethical principles, laboratory biosafety standards, and applicable regulatory frameworks governing animal use, biological materials, and bioactive substance handling. Our internal policies are continuously reviewed and updated to reflect advances in venom science, regulatory expectations, and best practices in laboratory animal management.
Through this comprehensive and responsible approach, G Biological Products aims to provide high-quality, ethically sourced scorpion venom while contributing to scientific innovation, therapeutic discovery, and sustainable biotechnology development.
Snake Breeding, Venom Extraction, and Venom Supply Policy
​
At G Biological Products, we implement a rigorous scientific, ethical, and sustainability-focused framework for the captive breeding of venomous snakes, the controlled extraction of venom, and the subsequent handling and supply of venom-derived materials. Snake venom is a highly complex biological secretion composed of enzymes, peptides, proteins, and low-molecular-weight bioactive compounds with critical applications in antivenom production, pharmaceutical research, diagnostic development, and advanced biotechnology. Our policies are designed to ensure animal welfare, biosafety, product consistency, and full traceability across all operational stages.
All venomous snakes maintained by G Biological Products are captive-bred and housed within high-security, controlled laboratory facilities. Our breeding programs are established to eliminate reliance on wild-caught specimens, thereby supporting conservation efforts and minimizing ecological impact. Housing conditions are species-specific and continuously monitored, including temperature gradients, humidity levels, enclosure design, enrichment protocols, feeding regimens, and health surveillance. Each animal is uniquely identified and documented to support long-term welfare monitoring and population management.
Venom extraction (milking) is performed using non-lethal, standardized manual or mechanical methods that allow for the safe collection of venom without causing permanent injury or unnecessary stress to the animal. Extraction frequency is strictly regulated in accordance with species-specific venom regeneration cycles and physiological recovery periods. All procedures are conducted by experienced venom specialists under validated standard operating procedures (SOPs), with strict adherence to occupational safety and animal welfare guidelines.
Following each extraction, snakes undergo routine post-milking observation to ensure normal behavior, feeding response, and physiological stability. Detailed records are maintained for every extraction event, enabling batch-level traceability and longitudinal assessment of venom yield and quality.
Collected venom is immediately transferred to controlled laboratory environments for stabilization, processing, and quality control. Depending on customer and research requirements, venom may be supplied in raw, clarified, lyophilized, or selectively fractionated forms. Quality assurance protocols include sterility testing, enzymatic and proteomic profiling, compositional consistency assessments, and validated storage conditions to preserve biological activity and safety.
G Biological Products operates in compliance with international biosafety standards, ethical animal use principles, and applicable regulatory frameworks governing the handling of venomous animals and biologically active substances. Our internal governance policies are regularly reviewed to incorporate advancements in toxinology, regulatory science, and best practices in laboratory animal care.
Through this structured and responsible approach, G Biological Products provides high-quality, ethically sourced snake venom while supporting antivenom development, translational research, and innovation across pharmaceutical and life science industries.
Regulatory and GMP-Adjacent Compliance Statement for Venom Production
G Biological Products conducts the breeding of venomous animals, venom extraction, processing, and supply activities in alignment with Good Manufacturing Practice (GMP) principles, ethical animal use standards, and internationally recognized biosafety and quality frameworks. While venom production may fall outside the scope of classical GMP for finished pharmaceutical products, all operational stages are designed to be GMP-adjacent, reproducible, auditable, and suitable for regulatory-supported research, antivenom manufacturing, and pharmaceutical development workflows.
​
Facility and Environmental Controls
Venom extraction and handling are performed within designated, access-controlled laboratory environments. Facilities are designed to minimize cross-contamination, ensure biosafety, and maintain environmental conditions appropriate for biological material handling. Environmental parameters, sanitation procedures, and pest control measures are documented and routinely monitored in accordance with internal quality standards.
​
Animal Management and Welfare Compliance
All venomous animals are captive-bred and maintained under documented animal welfare protocols consistent with internationally accepted ethical principles for laboratory animal care. Species-specific housing, feeding, health monitoring, and handling procedures are governed by written Standard Operating Procedures (SOPs). Animal use is limited to non-lethal venom extraction methods, and extraction schedules respect physiological recovery and venom regeneration cycles.
​
Standard Operating Procedures and Personnel Qualification
All critical activities, including animal handling, venom extraction, post-extraction monitoring, processing, storage, and shipment, are governed by controlled SOPs. Personnel involved in venom-related operations receive documented training in biosafety, animal handling, emergency response, and quality procedures. Competency assessments and refresher trainings are conducted at defined intervals.
​
Venom Collection, Processing, and Quality Control
Venom is collected using standardized, validated non-lethal extraction techniques. Immediately following extraction, venom is transferred to controlled laboratory conditions for stabilization and processing. Depending on intended use, venom may be supplied as crude, clarified, lyophilized, or fractionated material.
​
Quality control measures may include, as applicable:
-
Visual inspection and physical integrity checks
-
Sterility and bioburden screening
-
Protein and peptide profiling
-
Enzymatic or functional activity assessment
-
Lot consistency and stability evaluation
All analytical activities are documented, and results are reviewed under internal quality oversight.
​
Traceability and Documentation
Full traceability is maintained from animal identification through venom extraction, processing, packaging, and release. Each venom lot is assigned a unique batch identifier, with complete documentation including extraction date, processing method, storage conditions, and quality control status. Records are retained in accordance with internal data integrity and document control policies.
​
Storage, Packaging, and Distribution Controls
Venom materials are stored under validated temperature and containment conditions appropriate to their physical form and stability profile. Packaging and labeling are designed to ensure integrity during transport and to provide clear identification, handling instructions, and intended-use limitations. Distribution is restricted to qualified entities operating under appropriate regulatory and biosafety approvals.
​
Change Control, Deviations, and Continuous Improvement
Operational changes, deviations, or non-conformances are managed through a documented change control and corrective action framework. Internal reviews are conducted periodically to assess process performance, regulatory alignment, and opportunities for continuous improvement based on advances in toxinology, quality systems, and regulatory expectations.
​
Intended Use and Regulatory Positioning
Venom supplied by G Biological Products is intended for research use, diagnostic development, antivenom production, and pharmaceutical R&D. Unless explicitly stated otherwise, materials are not supplied as finished medicinal products. Customers are responsible for ensuring downstream compliance with applicable GMP, GLP, or clinical manufacturing requirements.
​
Through this structured GMP-adjacent quality framework, G Biological Products ensures that all venom materials are ethically sourced, scientifically characterized, traceable, and suitable for integration into regulated development pathways.
WHO-Aligned
Scorpion and Snake Venom Supply
​
G Biological Products supplies standardized scorpion venoms produced under ethical, traceable, and quality-controlled conditions to support antivenom research and manufacturing.
​
Our venom production framework is aligned with WHO technical expectations applicable to antivenom development, particularly regarding venom characterization, batch consistency, traceability, and reference material use.
​
Each venom batch is derived from species-verified scorpions, processed under controlled laboratory conditions, and released with comprehensive technical documentation suitable for regulatory and WHO-referenced antivenom dossiers.
​
G Biological Products acts as a reliable venom supplier for immunization programs, preclinical testing, and antivenom development initiatives.
​
Key capabilities include:
-
Species-verified venom sources (with voucher specimens and genetic confirmation where applicable)
-
Standardized venom pooling and batch-to-batch comparability programs
-
Full traceability from animal to vial
-
Ethical breeding and sustainable milking protocols
-
Technical documentation aligned with WHO anti-venom evaluation expectations
​
“WHO-aligned” refers to alignment with WHO technical guidance and does not imply WHO approval or certification.